Messeri PA, Abramson DM, Aidala AA, Lee F, Lee G. 2002. The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care 14(Suppl. 1):S15–S29.

MetLife. 2002. MetLife Market Survey on Nursing Home and Home Care Costs. Westport, CT: MetLife Mature Market Institute.

Moorman A, Delaney K, Palella F, Ashman D. 1998 (February 1). Recent Patterns of Antiretroviral Therapy (AR) and Clinical Response in Ambulatory HIV Patients. Paper presented at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, IL. Abstract 144/Session 24.

Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine 338(13):853–860.

Sambamoorthi U, Walkup J, Olfson M, Crystal S. 2000. Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. Journal of General Internal Medicine 15(5):311–320.

Schackman BR, Freedberg KA, Weinstein MC, Sax PE, Losina E, Zhang H, Goldie SJ. 2002.Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults. Archives of Internal Medicine 162(21):2478–2486.

Shapiro MF, Morton SC, McCaffrey DF, Senterfitt JW, Fleishman JA, Perlman JF, Athey LA, Keesey JW, Goldman DP, Berry SH, Bozzette SA. 1999. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association 281(24):2305–2315.

Sherer R, Stieglitz K, Narra J, Jasek J, Green L, Moore B, Shott S, Cohen M. 2002. HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care 14(Suppl. 1):S31–S44.

Simon GE, Von Korff M, Rutter CM, Peterson DA. 2001. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Archives of General Psychiatry 58(4):395–401.

Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, Schechter MT, Hogg RS. 1998. Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association 280(6):547–549.

Tengs TO, Wallace A. 2000. One thousand health-related quality-of-life estimates. Medical Care 38(6):583–637.

Turner BJ, Fleishman JA, Wenger N, London AS, Burnam MA, Shapiro MF, Bing EG, Stein MD, Longshore D, Bozzette SA. 2001. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine 16(9):625–633.

Wang PS, Demler O, Kessler RC. 2002. Adequacy of treatment for serious mental illness in the United States. American Journal of Public Health 92(1):92–98.

Zaric GS, Barnett PG, Brandeau ML. 2000. HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health 90(7):1100–1111.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement